Fuse Medical Reports First Quarter 2019 Results

Fuse Medical, Inc., (OTCPK: FZMD), a distributor and an emerging
manufacturer of medical devices for the orthopedic and spine
marketplace, announced that it has filed its quarterly report on Form
10-Q for the first quarter ended March 31, 2019, with the United States
Securities and Exchange Commission, on Tuesday, May 7, 2019.

Christopher C. Reeg, Chief Executive Officer, commented, “We are pleased
to announce improvements in our first quarter of 2019 results, with an
eleven (11) percentage point increase to gross profit and one (1)
percentage point improvement in earnings, as a percentage of net
revenues, compared to the same period one year ago. We believe our 2018
investment in product development has been instrumental to our
integrated distribution and manufacturing business model. Our focus
first quarter was to expand product development in our spine and
orthopedic implant offerings, for which we expect to see continued
growth and acceptance throughout the second quarter with significant
ramp-up in the last half of 2019.”

The filing can be found on the Company’s website at http://www.fusemedical.com/investors.

About Fuse Medical, Inc.

Fuse is a manufacturer and national distributor of medical devices,
providing a broad portfolio of internal and external fixation products;
upper and lower extremity plating and total joint reconstruction; soft
tissue fixation and augmentation for sports medicine procedures; full
spinal implants for trauma, degenerative disc disease, and deformity
indications, (collectively, “Orthopedic Implants”) and a wide array of
osteo-biologics, regenerative tissues, and amniotic tissue, including
human allografts, substitute bone materials and tendons, and
regenerative tissues and fluids (“Biologics”). The Company’s broad
portfolio of Orthopedic Implants and Biologics provide high quality
products that assist surgeons in providing positive patient outcomes and
cost-effective solutions. For more information about the Company, please
visit: www.fusemedical.com.

Forward-Looking Statements

Certain statements in this press release, including those related to an
anticipated purchase of all of the outstanding membership units and
plans for the consolidated company, constitute “forward-looking
statements” within the meaning of the federal securities laws. Words
such as “may,” “might,” “will,” “should,” “believe,” “expect,”
“anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,”
“plan,” “intend,” or similar expressions or statements regarding intent,
belief, or current expectations, are forward-looking statements. While
the Company believes these forward-looking statements are reasonable,
undue reliance should not be placed on any such forward-looking
statements, which are based only on information available to the Company
as of the date of this release. These forward-looking statements are
based upon current estimates and assumptions and are subject to various
risks and uncertainties, including, without limitation, those set forth
in the Company’s filings with the Securities and Exchange Commission;
the failure of the Company to close the transaction; and integration
issues with the consolidated company. Thus, actual results could be
materially different. The Company expressly disclaims any obligation to
update or alter statements whether as a result of new information,
future events, or otherwise, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190508005970/en/